Abstract
Tomohiro Hirade, Miho Wakuri, Daisuke Koike, Ryoji Nomura, Hidemasa Izumiya, Jun Kawase
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Escherichia coli O157.
10.1016/s0140-6736(10)60963-4 · 2010
Shiga toxin-producing Escherichia coli and the hemolytic-uremic syndrome.
10.1056/nejmra2108739 · 2023
Haemolytic uraemic syndrome.
10.1016/s0140-6736(22)01202-8 · 2022
2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea.
10.1093/cid/cix669 · 2017
Shiga toxin-producing Escherichia coli outbreak in Canadian daycare centers.
10.1001/jamanetworkopen.2026.1278 · 2026
The epidemiological and clinical characteristics of the largest outbreak of enterohemorrhagic Escherichia coli in Korea.
10.3346/jkms.2023.38.e117 · 2023
Outbreak of shiga toxin-producing Escherichia coli serotype O26: H11 infection at a child care center in Colorado.
10.1097/inf.0b013e3182457122 · 2012
Family clusters of Shiga toxin-producing Escherichia coli infection: an overlooked source of transmission. Data from the ItalKid-Hus network.
10.1097/inf.0000000000002877 · 2021
Outbreak of Escherichia coli O157:H7 in a child care center in Cook County, Illinois, with prolonged shedding and household transmission.
10.1016/j.ajic.2013.03.312 · 2013
Outbreak of enterohemorrhagic Escherichia coli O157:H7 infection associated with minced meat cutlets consumption in Kanagawa, Japan.
10.7883/yoken.jjid.2017.495 · 2018
Long-term survival of Shiga toxin-producing Escherichia coli O26, O111, and O157 in bovine feces.
10.1128/aem.65.11.5177-5181.1999 · 1999
An improved multiplex real-time SYBR green PCR assay for analysis of 24 target genes from 16 bacterial species in fecal DNA samples from patients with foodborne illnesses.
10.7883/yoken.jjid.2015.027 · 2016
New system for multilocus variable-number tandem-repeat analysis of the enterohemorrhagic Escherichia coli strains belonging to three major serogroups: O157, O26, and O111.
10.1111/j.1348-0421.2010.00252.x · 2010
Screening policies for daycare attendees: lessons learned from an outbreak of E. coli O157:H7 in a daycare in Waterloo, Ontario.
10.1007/bf03403755 · 2008
Shedding and exclusion from childcare in children with Shiga toxin-producing Escherichia coli, 2018-2022.
10.1017/s095026882400027x · 2024
Shiga toxin-producing Escherichia coli in diarrheal stool of Swedish children: evaluation of polymerase chain reaction screening and duration of Shiga toxin shedding.
10.1093/jpids/piv003 · 2016
Predicting hemolytic uremic syndrome and renal replacement therapy in Shiga toxin-producing Escherichia coli-infected children.
10.1093/cid/ciz432 · 2020
Duration of shedding of verocytotoxin-producing Escherichia coli in children and risk of transmission in childcare facilities in England.
10.1017/s095026881300109x · 2014
Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012.
10.1136/bmjopen-2015-009933 · 2016
Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.
10.1093/cid/cis299 · 2012
Associations between hydration status, intravenous fluid administration, and outcomes of patients infected with Shiga toxin-producing Escherichia coli: a systematic review and meta-analysis.
10.1001/jamapediatrics.2016.2952 · 2017
Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.
10.1007/s00467-016-3496-0 · 2017
Shiga toxin-producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome: a meta-analysis.
10.1093/cid/ciw099 · 2016
Impact of antibiotic treatment on hemolytic uremic syndrome risk in Escherichia coli O157 infections: a comprehensive systematic review and meta-analysis.
10.1007/s10096-025-05145-1 · 2025
Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota.
10.1097/inf.0b013e31823096a8 · 2012
Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
10.1016/j.jinf.2019.05.018 · 2019
The Shiga toxin 2 production level in enterohemorrhagic Escherichia coli O157:H7 is correlated with the subtypes of toxin-encoding phage.
10.1038/srep16663 · 2015
Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis.
10.1001/jama.288.24.3110-jlt1225-2-1 · 2002
Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts.
10.1093/oxfordjournals.aje.a010082 · 1999
Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996.
10.1046/j.1442-200x.1999.4121041.x · 1999
Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection.
1999
Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: a population-based matched case control study.
10.1371/journal.pone.0263349 · 2022
A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection.
10.1016/j.ijantimicag.2015.08.006 · 2015
The dilemma of antimicrobial treatment of Shiga toxin-producing Escherichia coli.
10.1097/inf.0000000000000425 · 2014
2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis.
10.1093/cid/ciw861 · 2017
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014.
10.1097/mpg.0000000000000375 · 2014
Risk factors associated with antibiotic prescriptions for cases of enteric pathogens in Canada, 2015-2019.
10.1017/s0950268824001365 · 2024
Antimicrobial prescribing practices for enteric bacterial infections in an integrated health care system, Wisconsin, 2004-2017.
10.1016/j.jiph.2024.102613 · 2025
Duration of shedding and secondary household transmission of Shiga toxin-producing Escherichia coli O26 during an outbreak in a childcare center, Oregon, October-December 2010.
10.1093/jpids/pis063 · 2012
Cost-effectiveness of excluding children with Shiga toxin-producing Escherichia coli (STEC) from childcare settings until microbiological clearance compared to return to childcare settings before microbiological clearance.
10.1017/s0950268825000196 · 2025
Antimicrobial therapy and shedding time of Shiga toxin-producing Escherichia coli.
10.1080/00365540802337059 · doi-reference
Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.
10.1001/jama.2012.264 · doi-reference
Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study.
10.1093/cid/cis1218 · doi-reference